|
PHARMACOKINETICS OF NORETHINDRONE-3-OXIME AND NORETHINDRONE IN RHESUS MONKEYS
|
|
|
炔诺酮肟(NETO)与炔诺酮(NET)在猴体内的药代动力学 |
|
PHARMACOKINETICS OF PHENYTOIN ZINC GIVEN ORALLY TO RABBITS
|
|
|
兔口服苯妥英锌的药物动力学 |
|
PHARMACOKINETICS OF PROPRANOLOL AND ITS METABOLITE 4-HYDROXYPROPRANOLOL
|
|
|
普萘洛尔及其代谢物4-羟普萘洛尔的药代动力学 |
|
PHARMACOKINETICS OF PUERARIN IN HEALTHY VOLUNTEERS
|
|
|
葛根素在健康志愿者的药代动力学 |
|
PHARMACOKINETICS OF SODIUM BIMETRONDAZOLE GLYCINATE IN MICE AND RATS
|
|
|
甘氨双唑钠在大鼠和小鼠体内药代动力学 |
|
PHARMACOKINETICS OF SOTALOL IN HEALTHY VOLUNTEERS
|
|
|
健康志愿者索他洛尔药代动力学 |
|
PHARMACOKINETICS OF SULFADIMIDINE AND ITS N_4-ACETYL METABOLITE IN RABBITS
|
|
|
磺胺二甲嘧啶及其N_4-乙酰化代谢物在兔的药动学研究 |
|
PHARMACOKINETICS OF SUPEROXIDE DISMUTASE IN MICE
|
|
|
超氧化物歧化酶在小鼠体内的药代动力学 |
|
PHARMACOKINETICS OF SUPEROXIDE DISMUTASE MODIFIED WITH LOW ANTICOAGULANT ACTIVITY HEPARIN
|
|
|
低抗凝活性肝素修饰超氧化物歧化酶的药代动力学研究 |
|
PHARMACOKINETICS OF SUSTAINED-RELEASE SODIUM VALPROATE IN 5 CHILDREN WITH EPILEPSY
|
|
|
丙戊酸钠缓释片在5例癫痫儿童的药物动力学 |
|
PHARMACOKINETICS OF THREE ￣(131)I-LABELLED ANTIBODIES IN IMMUNOTARGETING OF HEPATOCELLULAR CARCINOMA
|
|
|
肝癌导向治疗中三种~（131）I标记抗体的药代动力学观察 |
